Global Fund - 2025 |
|
|---|---|
|
State Department |
|
|
Programme |
|
|
Sub Programme |
|
|
Allocation: |
KES 23,922,425.00 (R) |
Key Performance Indicators
Key Output |
KPI |
Target Yr (2025) |
Target Yr (2026) |
Target Yr (2027) |
|---|---|---|---|---|
|
Disease Control Services |
No. of patients receiving Anti- Retroviral Therapy ART (Milllions) |
1.37 |
1.37 |
1.37 |
|
Disease Control Services |
No. of people receiving Artemisinin-Based Combination Therapy ACT (Millions) |
6.1 |
6.7 |
6.7 |
|
Disease Control Services |
% of Tuberculosis TB patients treated and tested for HIV |
100 |
100 |
100 |
User Uploads
Previous Year Allocations
Num |
Year |
Recurrent |
Development |
Total |
|---|---|---|---|---|
|
1 |
KES 23,922,425.00 |
KES 0.00 |
KES 23,922,425.00 |
|
|
2 |
KES 22,520,960.00 |
KES 0.00 |
KES 22,520,960.00 |
|
|
3 |
KES 11,101,456.00 |
KES 0.00 |
KES 11,101,456.00 |
|
|
4 |
KES 6,099,626.00 |
KES 0.00 |
KES 6,099,626.00 |
|
|
5 |
KES 6,269,135.00 |
KES 0.00 |
KES 6,269,135.00 |
No. of PPP projects approved: 7
KES 86,537,104.00
KES 83,748,179.00
(2025)
Donor Funds disbursed to MDAs as a % of the external resources mobilized: 100
KES 298,404,302.00
(2025)
No. of staff trained on project appraisal: 30
KES 50,000,000.00
(2025)